Media
|
Contact
|
Disclaimer
|
Careers
About us
Vision & Mission
Goal & Strategy
Values
Board of Directors
Management
Business Development
Oncology
Cancer at a glance
Belinostat
Mode of action
Clinical use
Safety profile
Indications and clinical program
Belinostat clinical studies
NCI- and Investigator Sponsored Trials
Belinostat abstracts - ASCO 2013
Science
Histone Deacetylase (HDAC)
Scientific publications
Glossary
Collaborators
Academic collaborators
Partners
Investor
About us
Vision & Mission
Goal & Strategy
Values
Board of Directors
Bo Jesper Hansen
Ingelise Saunders
Jeffrey H. Buchalter
Per Samuelsson
Anker Lundemose
Gisela Schwab
Karsten Witt
Management
Business Development
Board of Directors
Bo Jesper Hansen
Executive Chairman of the Board, board member since 2009
Ingelise Saunders
Board member since 2004
Jeffrey H. Buchalter
Board member since 2006
Per Samuelsson
Board member since 2009
Anker Lundemose
Board member since 2010
Gisela Schwab
Board member since 2011
Karsten Witt
Board member since 2011